Login / Signup
Amber James
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 3
Top Topics
Low Density Lipoprotein
Smoking Cessation
Cystic Fibrosis
Top Venues
Pharmacotherapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Kevin Lonabaugh
,
Galvin Li
,
Rhonda List
,
Reyna Huang
,
Amber James
,
Andrew Barros
,
Lindsay Somerville
,
Dana Albon
Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis.
Pharmacotherapy
44 (3) (2024)
Kevin Lonabaugh
,
Galvin Li
,
Rhonda List
,
Reyna Huang
,
Amber James
,
Andrew Barros
,
Lindsay Somerville
,
Dana Albon
Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis.
Pharmacotherapy
44 (3) (2024)
Kevin Lonabaugh
,
Galvin Li
,
Rhonda List
,
Reyna Huang
,
Amber James
,
Andrew Barros
,
Lindsay Somerville
,
Dana Albon
Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis.
Pharmacotherapy
(2023)